J. Lang

发表

Genome-wide association study identifies three loci associated with melanoma risk

J. Malvehy, S. Puig, E. Gillanders, 2009, Nature Genetics.

Genome-wide association study identifies three new melanoma susceptibility loci

Jeffrey E. Lee, J. Malvehy, S. Puig, 2011, Nature Genetics.

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents

S. Puig, E. Gillanders, D. Elder, 2006, Journal of Medical Genetics.

Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways

David M. Evans, Jeffrey E. Lee, A. Uitterlinden, 2017, bioRxiv.

Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes.

R. MacKie, J. Lang, 2005, The Journal of investigative dermatology.

Absence of exon 15 BRAF germline mutations in familial melanoma

R. MacKie, J. Lang, M. Boxer, 2003, Human mutation.

Selection criteria for genetic assessment of patients with familial melanoma.

A. Halpern, S. Puig, S. Swetter, 2009, Journal of the American Academy of Dermatology.

The M53I mutation in CDKN2A is a founder mutation that predominates in melanoma patients with Scottish ancestry

N. Hayward, E. Tobias, M. Stark, 2007, Genes, chromosomes & cancer.

families from three continents mutations: a GenoMEL study of melanoma-prone Features associated with germline CDKN2A

S. Puig, E. Gillanders, D. Bishop, 2007 .

A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds.

S. Puig, N. Hayward, M. Tucker, 2011, The Journal of investigative dermatology.

Preliminary evidence for involvement of the tumour suppressor gene CHD5 in a family with cutaneous melanoma

E. Tobias, R. MacKie, J. Lang, 2011, The British journal of dermatology.

CDKN2A mutations in Scottish families with cutaneous melanoma: results from 32 newly identified families

R. MacKie, J. Lang, M. Boxer, 2005, The British journal of dermatology.

High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.

S. Puig, E. Gillanders, D. Bishop, 2006, Cancer research.

Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma

Marko Hočevar, Kevin M. Brown, Florence Demenais, 2015, Nature Genetics.

Genome-wide association meta-analyses combining multiple risk phenotypes provides insights into the genetic architecture of cutaneous melanoma susceptibility

Blair H. Smith, Jeffrey E. Lee, G. Abecasis, 2020, Nature Genetics.

A variant in FTO shows association with melanoma risk not due to BMI

Marko Hočevar, Florence Demenais, Kari Stefansson, 2013, Nature Genetics.

Genome-wide association meta-analyses combining multiple risk phenotypes provides insights into the genetic architecture of cutaneous melanoma susceptibility

Blair H. Smith, Jeffrey E. Lee, G. Abecasis, 2020, Nature Genetics.

Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148

Geoffrey S. Tobias, K. Nielsen, J. Malvehy, 2017, Nature Communications.

The Effect on Melanoma Risk of Genes Previously Associated With Telomere Length

Jeffrey E. Lee, S. Puig, E. Gillanders, 2014, Journal of the National Cancer Institute.

Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study

S. Puig, E. Gillanders, D. Elder, 2010, Journal of the National Cancer Institute.

Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions

S. Puig, E. Gillanders, K. Brown, 2014, International journal of cancer.

Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways

David M. Evans, A. Uitterlinden, T. Spector, 2017, Nature Communications.

Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma

D. Schadendorf, S. Puig, E. Gillanders, 2015, Nature Genetics.

Preliminary evidence for involvement of the tumour suppressor gene CHD5 in a family with cutaneous melanoma

J. Lang, R. Mackie, Edward S. Tobias, 2011, The British journal of dermatology.